Riskpilot← Back to searchSign inGet full accessFYRESDAL DYREKLINIKK AS
ASActiveOrg 999001386Folkestadgata 24, 3870 FyresdalVeterinary activities · NACE 7500Est. 20124 employees
Revenue 2024
NOK 2,3M
-50% vs 2023
EBITDA margin
-25.0%
-137% vs 2023
Equity ratio
82.8%
Financial strength
Net profit 2024
NOK -844K
-84% vs 2023
| Revenue | NOK 2,3M | -50% |
| EBITDA | NOK -575K | -137% |
| Net profit | NOK -844K | -84% |
| Total assets | NOK 2,3M | -35% |
| Equity | NOK 1,9M | -30% |
| Employees | 4 | — |
Legal name
FYRESDAL DYREKLINIKK AS
Org number
999001386
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
13. oktober 2012
Share capital
NOK 150 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Veterinærvirksomhet, salg av tilhørende produkter og annen virksomhet i tilknytning til dette. Selskapet kan også delta i andre selskaper.
Address
Folkestadgata 24, 3870 Fyresdal
Phone
+4791006700
Email
post@dyreklinikkensor.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 648 | 6 099 | 5 641 | 4 613 | 2 296 |
| Staff expenses | −2 441 | −2 341 | −1 928 | −1 718 | −820 |
| EBITDA | 529 | 328 | 397 | −243 | −575 |
| Depreciation & amort. | −415 | −441 | −354 | −349 | −366 |
| EBIT | 114 | −112 | 43 | −591 | −941 |
| Net financials | 7 | −0 | 0 | 4 | 3 |
| Profit before tax | 122 | −112 | 43 | −587 | −938 |
| Tax | 28 | −25 | 10 | −128 | −94 |
| Net profit | 93 | −88 | 34 | −459 | −844 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 310 | 4 926 | 4 613 | 3 612 | 2 347 |
| Equity | 3 643 | 3 612 | 3 646 | 2 787 | 1 943 |
| Long-term debt | 222 | 213 | 222 | 94 | 0 |
| Short-term debt | 1 446 | 1 101 | 745 | 732 | 405 |
| Total debt | 1 667 | 1 314 | 968 | 826 | 405 |
EBITDA margin
-25.0%
This company
15.8%
Market median
-258% vs market
20202024
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20202024
Return on equity
-43.4%
This company
18.4%
Market median
-336% vs market
20202024
Net profit margin
-36.8%
This company
8.1%
Market median
-554% vs market
20202024
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Deputy Member | Deputy Member | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jesper Holding As
FYRESDAL DYREKLINIKK AS Board members of FYRESDAL DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arild Beylegaard Pedersen | Deputy Member | 0 companies |
| Anja Cecilie Beylegaard Pedersen | Chairman | 0 companies |
| Kristian Stormyr | Board of Directors | 0 companies |
| Andre Beylegaard Pedersen | Board of Directors | 0 companies |